<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04844879</url>
  </required_header>
  <id_info>
    <org_study_id>P02.022.02</org_study_id>
    <nct_id>NCT04844879</nct_id>
  </id_info>
  <brief_title>Medacta NextAR TKA Pivotal Trial</brief_title>
  <official_title>Prospective, Multicentre, Single-arm, Open, Confirmatory Trial to Assess Efficacy and Safety of a Navigation System Providing Personalized Soft Tissue Balance Data in Medially-stabilized Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medacta International SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medacta International SA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to assess the efficacy and safety of a navigation system providing&#xD;
      personalized soft tissue balance data in medially-stabilized total knee arthroplasty (TKA).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, multicentre, single-arm, open, confirmatory clinical investigation to&#xD;
      assess the efficacy and safety of a navigation system providing personalized soft tissue&#xD;
      balance data in medially-stabilized total knee arthroplasty (TKA).&#xD;
&#xD;
      Participants will be informed about the study, both orally and in writing, during a&#xD;
      preoperative visit. The investigator will answer any questions that may arise and will&#xD;
      collect the informed consent. During the study, enrolled participants will be able to&#xD;
      withdraw at any time and for any reason.&#xD;
&#xD;
      The study is conducted according to the following schedule:&#xD;
&#xD;
        -  V1 : Inclusion during a preoperative visit&#xD;
&#xD;
        -  V2: Surgery&#xD;
&#xD;
        -  V3: Follow-up visit at 2 month post-surgery&#xD;
&#xD;
        -  V4: Follow-up visit at 6 months post-surgery&#xD;
&#xD;
        -  V5: Follow-up visit at 12 months post-surgery&#xD;
&#xD;
      The following data will be collected:&#xD;
&#xD;
        -  Oxford Knee Score (OKS), Knee Society Score (KSS), Forgotten Joint Score (FJS) and&#xD;
           patient satisfaction at 6 months and 12 months of follow-up;&#xD;
&#xD;
        -  Radiological analysis at 2 and 12 months of follow-up;&#xD;
&#xD;
        -  Surgical time (min);&#xD;
&#xD;
        -  Necessity of soft tissue release to obtain ligament or patellar balance;&#xD;
&#xD;
        -  Time to discharge (days);&#xD;
&#xD;
        -  Device deficiencies and peri- and postoperative adverse events.&#xD;
&#xD;
      A web-based data collection tool will be used as Electronic Data Capture (EDC). All the&#xD;
      information required by the protocol will be collected in electronic case report forms&#xD;
      (eCRF).&#xD;
&#xD;
      The statistical analysis will be performed according to a pre-established statistical&#xD;
      analysis plan. Missing values will not be replaced by estimated values but will be considered&#xD;
      as missing in the statistical analysis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 17, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional outcome</measure>
    <time_frame>6 months</time_frame>
    <description>Oxford Knee Score (OKS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional outcome</measure>
    <time_frame>12 months</time_frame>
    <description>Oxford Knee Score (OKS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional outcome</measure>
    <time_frame>6 months and 12 months</time_frame>
    <description>Forgotten Joint Score (FJS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical and functional outcome</measure>
    <time_frame>6 months and 12 months</time_frame>
    <description>Knee Society Score (KSS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological outcomes</measure>
    <time_frame>2 months and 12 months</time_frame>
    <description>Radiological assessment including implant positioning, presence of radiolucent lines, subsidence, migration of components, presence of heterotopic ossifications or osteolysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical outcome</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Surgical time (min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical outcome</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Necessity of soft tissue release to obtain ligament or patellar balance (Y/N)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical outcome</measure>
    <time_frame>Immediate postoperative</time_frame>
    <description>Time to discharge (days)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety outcomes</measure>
    <time_frame>Intraoperative, 2 months, 6 months and 12 months</time_frame>
    <description>Device deficiencies and adverse events</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Musculoskeletal Diseases</condition>
  <arm_group>
    <arm_group_label>Single-arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients suitable to receive Medacta GMK® Sphere system for primary TKA will be invited to take part to the study during the preoperative visit. Follow-ups are performed after 2, 6 and 12 months. Data collection includes clinical and radiological data for preoperative and postoperative assessments, as well as intraoperative details.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NextAR TKA system</intervention_name>
    <description>The NextAR TKA system is a surgical guidance system which measures intra-operatively the effect of prosthesis alignment and positioning on soft tissue balance.</description>
    <arm_group_label>Single-arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Males and females aged over 18 years at time of surgery.&#xD;
&#xD;
          2. Patients who are scheduled to receive Medacta GMK® Sphere system for primary TKA&#xD;
             (class III, CE-marked).&#xD;
&#xD;
          3. Patients with functional contralateral knee (i.e. without the need to use walking&#xD;
             aids).&#xD;
&#xD;
          4. Patients willing and able to provide written informed consent for participation.&#xD;
&#xD;
          5. Patients willing to comply with the pre and post-operative evaluation schedule.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with one or more medical conditions identified as a contraindication defined&#xD;
             by the labelling on any Medacta implants used in this study:&#xD;
&#xD;
               -  Patients presenting with progressive local or systemic infection&#xD;
&#xD;
               -  Muscular loss, neuromuscular disease or vascular deficiency of the affected limb,&#xD;
                  making the operation unjustifiable.&#xD;
&#xD;
               -  Severe instability secondary to advanced destruction of condralar structures or&#xD;
                  loss of integrity of the medial or lateral ligament&#xD;
&#xD;
          2. Patients whose prospects for a recovery to independent mobility would be compromised&#xD;
             by known coexistent, medical problems.&#xD;
&#xD;
          3. Patients affected by concomitant spine, hip, ankle or contralateral knee pathologies&#xD;
             that can affect walking capacity.&#xD;
&#xD;
          4. Patients unable to understand and take action.&#xD;
&#xD;
          5. Patients with known allergy to the materials used.&#xD;
&#xD;
          6. Patients in which Medacta GMK® Sphere system is used in emergency interventions.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandro Fucentese, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Balgrist University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Denise Falcone, PhD</last_name>
    <phone>+41916966060</phone>
    <email>falcone@medacta.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Privatklinik Belair</name>
      <address>
        <city>Schaffhausen</city>
        <zip>8200</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Koch, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Privatklinik Lindberg</name>
      <address>
        <city>Winterthur</city>
        <zip>8400</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Koch, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kantonsspital Winterthur</name>
      <address>
        <city>Winterthur</city>
        <zip>8401</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Uniklinik Balgrist</name>
      <address>
        <city>Zurich</city>
        <zip>8008</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandro Fucentese, Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 8, 2021</study_first_submitted>
  <study_first_submitted_qc>April 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2021</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>total knee arthroplasty</keyword>
  <keyword>surgical navigation</keyword>
  <keyword>medially-stabilized TKA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Musculoskeletal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

